Stay up to date

Another CEPI partner, Clover Biopharmaceuticals, has become the latest vaccine developer to sign an advance purchase agreement with COVAX to make their COVID-19 vaccine available to populations worldwide.
Under the new agreement between Clover and our COVAX partner, Gavi, up to 414 million doses are set to be made available to participating countries in 2021 and 2022. CEPI’s significant early investments have been critical to the development of Clover’s vaccine candidate, and were directly linked to access commitments which enabled this deal.

Since late Spring, 2020, CEPI has provided up to $328 million to support preclinical and clinical testing of the candidate vaccine, in addition to scaling-up the biotech’s in-house manufacturing capacity. Clover yesterday announced that its pivotal global Phase 2/3 clinical trial—funded by CEPI—is now fully enrolled, and that interim efficacy data is expected in Q3.
COVAX has now distributed over 100 million vaccines since its launch in February this year. Supply of Clover’s vaccine is anticipated to start in the last quarter of the year, pending Emergency Use Licensure from the World Health Organization (WHO).

To learn more visit https://cepi.net/news_cepi/from-lab-to-potential-jab-clovers-covid-19-vaccine-story/

We are pleased to inform you that abstract submission is open for the Microbiome & HIV Workshop 2021. Researchers are invited to present their latest studies or share their experiences in the microbiome and HIV field until 5 September 2021.

Abstracts can be submitted under the following categories:
• Comorbidities
• Microbicides / Vaccines
• Pathogenesis
• Technologies & Methodologies
• Transmission & Prevention
• Treatment & Cure

Young Investigators and Academia from Resource-Limited Settings with accepted abstracts will be provided with a registration waiver fee to join the workshop.
Visit our website for further information on abstract submission and available discounts for submitters - https://academicmedicaleducation.com/microbiome-hiv-2021

The Africa Research Excellence Fund (AREF) is calling for applications from active, emerging health-researchers in Sub-Saharan Africa to participate in its sixth Essential Grant Writing Skills Workshop. This fully on-line programme for up to 6 participants will be held over eight 3-hour sessions during the weeks of 14 December 2020 and 4 January 2021.

Workshop aim: The Workshop aim is to enable talented early-career health- and health-related researchers to build skills to develop their own research and fellowship proposals of the quality required to win competitive international, regional and national funding.

What the Workshop will cover:

1. Why competitive-proposal writing matters
2. Understanding funders’ requirements
3. Formulating your compelling research question
4. Writing in plain English
5. Writing your Letter of Intent / Concept Note / Preliminary proposal
6. Key parts of a typical Case for Support / Project Description
7. Planning your proposal project plan and budget
8. Principles of managing your collaboration and team
9. Understanding and practicing peer review
10. Preparing for a Fellowship interview.

What the Workshop will not cover:

The workshop will not cover the following: how to manage research ethics approval; how to complete individual funders’ application forms; the details of intellectual property management; practice in research communication. The facilitators will use examples of real funding applications. However, they will not be assisting participants directly with the participants’ own specific proposals. 

For more information visit https://www.africaresearchexcellencefund.org.uk/essential-grant-writing-skills-workshop-december-2020-january-2021

The South African Medical Research Council participates in the Global Alliance for Chronic Diseases, a collaboration of major international research funding agencies that support joint funding calls and research capacity building activities to address chronic, non-communicable diseases. The alliance focuses on implementation research in low- and middle- income countries (LMICs) and in vulnerable and indigenous populations in high-income countries (HICs).

The GACD have announced the launch of the Implementation Science e-Hub. The e-Hub is a free, virtual platform for knowledge and skill development in implementation research. It is intended for researchers, students, policymakers and practitioners at any stage in their career, from anywhere in the world, interested in improving their knowledge of implementation research, especially its application for the prevention and management of non-communicable diseases in low-resource settings.

For more information visit https://implementationscience-gacd.org/